A Decade of Shifting Minds: How Europe Learned to Live With Cannabis

October 8, 2026

Photo by Jakub Zerdzicki via Pexels.

In 2008, Flash Eurobarometer researchers asked a representative sample of young Europeans what should happen to cannabis, and two-thirds of them said ban it — the same instinct they applied to heroin and cocaine, lumped together as if the drugs were interchangeable in risk and consequence. Run that same question forward to the early 2020s and the picture is almost unrecognizable: polling across eight major European countries found a solid majority now backs legal retail sales of cannabis, not just decriminalization or medical access, but actual stores. That is not a minor drift in survey noise. It is a generational reversal on a question that European governments had treated as settled for decades.

But the story isn't a tidy line from prohibition to acceptance, country by country, in lockstep. It's closer to a weather system — moving fast in some places, stalling in others, occasionally blowing backward. Germany legalized home cultivation in 2024. Czechia's Senate pushed through adult-use reform in mid-2025, taking effect January 2026. Malta and Luxembourg got there earlier still. Meanwhile France, which briefly had a legalization-leaning majority in 2021, swung back toward opposition by 2024, and Poland's public remains visibly anxious that any cannabis reform becomes a gateway to recreational normalization. Lawmakers in some capitals are now running ahead of where their own citizens stand; in others, the public has outpaced politicians who won't touch the issue. Understanding which is which — and why — says more about where Europe is headed than any single continent-wide average ever could.

The Slow Break From 'All Drugs Are Equal'

Photo by Alexis Brown via Unsplash.

The best early evidence that something was shifting in European attitudes doesn't come from a legalization poll at all — it comes from a series of Flash Eurobarometer surveys that the European Commission ran among 15-24 year-olds between 2008 and 2014, originally designed to track youth attitudes toward drugs broadly. Buried in that data is a quiet but significant signal: support for banning cannabis outright fell from 67.6% in 2008 to 53.7% in 2014, a drop of nearly fourteen points in six years. That's a meaningful swing for any policy question tracked by the same methodology over a short window.

What makes the number worth dwelling on is the comparison baked into the same surveys. Support for banning heroin, ecstasy and cocaine barely moved during that stretch, staying pinned above 90% the entire time. Young Europeans weren't becoming more permissive about drugs generally — they were becoming more specific. They started treating cannabis as categorically different from the rest of the illicit drug basket, years before legalization was a serious item on any national legislature's agenda.

This matters for how you read everything that came after. The dramatic polling swings of the 2020s — majority support for legal retail sales, governments actually passing cultivation and possession reforms — can look sudden if you only start the clock in 2018 or so. They weren't sudden. The Eurobarometer numbers show the groundwork being laid a full decade earlier, among the cohort that would become the core voting and consuming public by the time Germany and Czechia moved on legislation. The 2008-2014 data is the first hard evidence that cannabis had broken loose from the all-drugs-are-equal framing that had anchored European drug policy since the 1961 UN Single Convention. Everything downstream — the 2021 pan-European poll, the legislative wave in Germany and Czechia — builds on that foundation rather than appearing out of nowhere.

2021: The Poll That Showed a Continent Had Changed Its Mind

Photo by Joshi Milestoner via Unsplash.

If there's one survey that European cannabis operators and investors still cite when they're pitching a market thesis, it's the Hanway Associates poll conducted with Curaleaf, Cansativa and Ince between February 24 and March 14, 2021. It surveyed 9,043 adults aged 18 and over across France, Germany, Italy, Spain, the Netherlands, Portugal, Switzerland and the UK — a genuinely large, cross-national sample at a moment when most European cannabis polling had been fragmented, country-specific, and inconsistent in methodology.

The topline numbers were stark: 55% of respondents supported legalizing adult-use cannabis, 25% opposed it, and 18% said they were unsure. Nearly a third — 30% — said they'd be personally interested in trying legal cannabis if it became available, a figure that told industry analysts something about latent demand beyond existing consumers. Dig into the supporters' preferences and the picture gets more interesting: 81% wanted retail stores as the access model, 62% backed home cultivation rights, and 56% liked the idea of social clubs — the Spanish-style cooperative model that had already existed in legal gray zones in Barcelona and elsewhere.

The country breakdown is where the poll earned its reputation as a genuine inflection point rather than just another survey. Every single country sampled showed outright majority support for legalization — except the Netherlands, which registered only a plurality. That's a counterintuitive result worth sitting with: the country most associated internationally with cannabis tolerance, thanks to decades of coffeeshop policy, turned out to have a public that was less enthusiastic about formal legalization than France or Germany. The likely explanation is that Dutch respondents already felt they had functional access through the coffeeshop system and saw less urgency in full legal retail — tolerance had already solved the practical problem, even if the underlying law never changed. That nuance aside, the 2021 poll became the reference point that industry pitch decks, parliamentary debates and newsroom explainers across the continent leaned on for the next several years, because it was the first time anyone had the numbers to say, credibly, that a majority of Europeans wanted legal cannabis sales.

Policy Catches Up: Germany, Malta, Luxembourg and Czechia

Photo by Diyahna Lewis via Unsplash.

Legislatures move slower than public opinion, which is why it took roughly three years after the 2021 poll for the first large European country to act on its findings. Germany got there in 2024, legalizing home cultivation and making it the most populous country in Europe to do so — a genuinely significant marker, since Germany's size means its policy choices tend to pull neighboring debates along with them. Early post-legalization research found that around 10% of Germans report having grown cannabis at home since the law changed, and surveys of those growers found expectations about the consequences — for their families, their employment, their communities — were mostly positive rather than the feared disruption that opponents had warned about.

Czechia followed with its own adult-use reform, passed by the Senate in July 2025 with a 47-to-15 vote among the 62 senators present, set to take effect January 1, 2026. The Czech model allows adults to grow up to three plants at home and possess up to 100 grams privately, with a lower public-possession limit of 25 grams. Notably, retail sales remain banned under the new law — Czechia is legalizing possession and cultivation while stopping well short of the dispensary model that polling shows most Europeans actually prefer. That gap between what the law allows and what the public told pollsters it wanted is likely to be the next flashpoint in Czech policy debates.

Malta and Luxembourg had already moved earlier in this window, each adopting more limited legalization and decriminalization frameworks before Germany or Czechia acted, effectively serving as the first test cases for how a small EU member state handles reform without triggering diplomatic friction over international drug treaty obligations. Taken together, these four countries aren't acting in isolation from each other or from public sentiment — they're legislative responses tracking, with a lag, the same majority-support numbers the 2021 pan-European poll documented. The policy wave is catching up to where the public already was.

Where Opinion Is Still Split or Souring: UK, France, Poland

While the Pan-European average shows strong majority support for cannabis legalization (55% support vs. 25% oppose), UK attitudes in 2026 are much more evenly split, with 47% in support and 43% opposed.

Not every country is moving the same direction, and the clearest counterexample sits right across the Channel. A YouGov poll of 2,053 UK adults in April 2026 found that 37% had used cannabis at least once in their lives, rising to 47% among 25-49 year-olds — essentially half that age bracket. You'd expect that level of lived experience with the drug to translate into lopsided support for legalization. It doesn't. Support sits at 47% against 43% opposed, a four-point margin that's well within the range of a genuinely divided public rather than a quiet reform consensus waiting to be legislated.

The division gets sharper when YouGov gave respondents three distinct policy options instead of a binary for-or-against question. Offered the choice between keeping cannabis a criminal offence, decriminalizing it, or fully legalizing it, 35% of Britons picked keeping it criminal and only 33% picked full legalization — meaning the plurality position in the UK right now is actually the status quo, not reform. That's a meaningfully different story than the one the 2021 Hanway poll told, and it's a reminder that high rates of personal cannabis use don't automatically produce political consensus for changing the law.

France tells an even more pointed story about opinion moving backward. Ifop and Statista have tracked French attitudes toward cannabis since 1977, one of the longest continuous polling series in Europe on the subject, and it recorded legalization supporters becoming a majority for the first time ever in 2021 — the same year as the broader European poll. By 2024, that majority had evaporated, with the French public mostly opposed to decriminalization again. Poland adds a Central European data point in the same direction: a 2025/2026 survey found 32.4% of respondents worried that legalizing medical cannabis could fuel recreational use, a caution that tracks with the broader hesitancy seen across much of Central and Eastern Europe. The lesson across all three countries is the same — liberalization isn't a one-way ratchet. France in particular shows that a legalization majority can peak and recede within a few years, which complicates any assumption that European opinion only ever moves in one direction.

Zoom out across the full fifteen-plus years of data and the direction is unmistakable: fewer Europeans want cannabis treated the way they treat heroin or cocaine, more are comfortable with legal retail access, and four countries have now written that sentiment into law. But zoom back in and the pace is wildly uneven — Germany and Czechia moving with real legislative teeth, France souring on an idea it briefly embraced, the UK locked in a near-even split despite nearly half its adults under 50 having tried the drug, Poland openly wary of where medical reform might lead.

Two open questions are worth watching more closely than any EU-wide average. First, whether Czechia eventually closes the gap between its current possession-and-cultivation law and the retail model that polling consistently shows Europeans actually prefer — if Prague adds dispensary-style sales in the next few years, it becomes the clearest test of whether policy can fully catch public opinion rather than just gesture toward it. Second, whether France's 2024 pullback is a temporary stumble or a new ceiling on how far French opinion will go — a country with one of the longest polling histories on this exact question reversing course is a bigger signal than a one-off survey from a smaller state.

What's changing now is the feedback loop itself. For most of the period covered here, polling ran ahead of policy and politicians eventually, cautiously, followed. Germany's and Czechia's new laws flip that relationship: they'll generate the first large-scale, real-world data on what actually happens when tens of millions of people get legal access to home cultivation and modest possession limits — effects on youth use, on illicit markets, on public health systems. That data will shape the next round of polling, which will shape the next round of legislation elsewhere. Europe's cannabis debate has stopped being a referendum on an abstract idea and started being a comparison of live policy experiments, which is a much harder thing for any country to ignore.